Kert Viele

2.9k total citations · 2 hit papers
56 papers, 1.5k citations indexed

About

Kert Viele is a scholar working on Statistics and Probability, Management Science and Operations Research and Artificial Intelligence. According to data from OpenAlex, Kert Viele has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Statistics and Probability, 9 papers in Management Science and Operations Research and 8 papers in Artificial Intelligence. Recurrent topics in Kert Viele's work include Statistical Methods in Clinical Trials (15 papers), Advanced Causal Inference Techniques (6 papers) and Statistical Methods and Bayesian Inference (6 papers). Kert Viele is often cited by papers focused on Statistical Methods in Clinical Trials (15 papers), Advanced Causal Inference Techniques (6 papers) and Statistical Methods and Bayesian Inference (6 papers). Kert Viele collaborates with scholars based in United States, United Kingdom and France. Kert Viele's co-authors include Anna McGlothlin, Scott Berry, Barbara Tong, Robin L. Cooper, Kristine Broglio, Nelson Kinnersley, Satrajit Roychoudhury, Stacy Lindborg, Sandrine Micallef and Laura Thompson and has published in prestigious journals such as JAMA, Bioinformatics and Cancer.

In The Last Decade

Kert Viele

51 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of historical control data for assessing treatment effects in clinical trials

2013 327 citations Kert Viele, Scott Berry et al. Pharmaceutical Statistics profile →
Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

2020 314 citations Kert Viele et al. profile →

Peers

Countries citing papers authored by Kert Viele

Since Specialization

Citations

This map shows the geographic impact of Kert Viele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kert Viele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kert Viele more than expected).

Fields of papers citing papers by Kert Viele

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kert Viele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kert Viele. The network helps show where Kert Viele may publish in the future.

Co-authorship network of co-authors of Kert Viele

This figure shows the co-authorship network connecting the top 25 collaborators of Kert Viele. A scholar is included among the top collaborators of Kert Viele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kert Viele. Kert Viele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Design and methods of an adaptive trial to test comparative effectiveness of readmission reduction approaches following infection and sepsis hospitalizations (ACCOMPLISH) 2025 ·Contemporary Clinical Trials Communications ·(unknown), Victor B. Talisa, (unknown), Florian Mayr, Kelly Williams, (unknown), Richard J. Wadas, Elizabeth Lorenzi, Kert Viele, Rana Awdish, Derek C. Angus, (unknown), Sachin Yende	0
2	Ethical clinical trial design and differences in treatment effects 2025 ·Bulletin of the World Health Organization ·Roger Lewis, Kert Viele, Margareth Ndomondo-Sigonda, Samba O. Sow, Elvis Temfack, Nathalie Strub‐Wourgaft	0
3	Effects of Allocation Method and Time Trends on Identification of the Best Arm in Multi-Arm Trials 2024 ·Statistics in Biopharmaceutical Research ·Lindsay R. Berry, Elizabeth Lorenzi, Nicholas Berry, (unknown), Peter Jacko, Kert Viele	5
4	On model-based time trend adjustments in platform trials with non-concurrent controls 2022 ·BMC Medical Research Methodology ·(unknown), (unknown), Carl‐Fredrik Burman, Ekkehard Glimm, Stefan M. Gold, Katharina Hees, Peter Jacko, Franz Koenig, Dominic Magirr, Peter Mesenbrink, Kert Viele, Martin Posch	30
5	Design and logistical considerations for the randomized adaptive non-inferiority storage-duration-ranging CHIlled Platelet Study 2022 ·Clinical Trials ·Nicole D. Zantek, Marie E. Steiner, John M. VanBuren, Roger Lewis, Nicholas Berry, Kert Viele, (unknown), J. Michael Dean, Stacy A. C. Nelson, Philip C. Spinella	7
6	Strategies to Promote ResiliencY (SPRY): a randomised embedded multifactorial adaptative platform (REMAP) clinical trial protocol to study interventions to improve recovery after surgery in high-risk patients 2020 ·BMJ Open ·Katherine M. Reitz, Christopher Seymour, (unknown), Melanie Quintana, Kert Viele, Michelle A. Detry, Michael J. Morowitz, Alison Morris, Barbara A. Methé, Jason Kennedy, Brian S. Zuckerbraun, Timothy D. Girard, Oscar C. Marroquin, Stephen A. Esper, Jennifer Holder‐Murray, Anne B. Newman, Scott Berry, Derek Angus, Matthew D. Neal	9
7	Comparison of response adaptive randomization features in multiarm clinical trials with control 2020 ·Pharmaceutical Statistics ·Kert Viele, Benjamin R. Saville, Anna McGlothlin, Kristine Broglio	20
8	Comparison of methods for control allocation in multiple arm studies using response adaptive randomization 2019 ·Clinical Trials ·Kert Viele, Kristine Broglio, Anna McGlothlin, Benjamin R. Saville	31
9	Using Bayesian adaptive designs to improve phase III trials: a respiratory care example 2019 ·BMC Medical Research Methodology ·Elizabeth Ryan, Julie Bruce, Andrew Metcalfe, Nigel Stallard, Sarah E Lamb, Kert Viele, Duncan Young, Simon Gates	27
10	Reducing Patient Burden in Clinical Trials Through the Use of Historical Controls: Appropriate Selection of Historical Data to Minimize Risk of Bias 2019 ·Therapeutic Innovation & Regulatory Science ·Jessica Lim, Li Wang, Nicky Best, Jeen Liu, Jiacheng Yuan, Florence H. Yong, Lanju Zhang, Rosalind Walley, (unknown), Robert Roebling, Kert Viele	13
11	The design of an adaptive clinical trial to evaluate the efficacy of platelets stored at low temperature in surgical patients 2018 ·The Journal of Trauma: Injury, Infection, and Critical Care ·(unknown), Kert Viele, Philip C. Spinella, Marie E. Steiner, Nicole D. Zantek, Roger Lewis	14
12	Effect of Levocarnitine vs Placebo as an Adjunctive Treatment for Septic Shock: The Rapid Administration of Carnitine in Sepsis (RACE) Randomized Clinical Trial 2018 ·PMC ·Alan E. Jones, Michael A. Puskarich, Nathan I. Shapiro, Faheem W. Guirgis, Michael S. Runyon, Jason Y. Adams, Robert Sherwin, Ryan Arnold, Brian W. Roberts, Michael C. Kurz, Henry E. Wang, Jeffrey A. Kline, D. Mark Courtney, Stephen Trzeciak, Sarah A. Sterling, Utsav Nandi, (unknown), Kert Viele	4
13	An Adaptive, Phase II, Dose-Finding Clinical Trial Design to Evaluate L-Carnitine in the Treatment of Septic Shock Based on Efficacy and Predictive Probability of Subsequent Phase III Success 2013 ·Critical Care Medicine ·Roger Lewis, Kert Viele, Kristine Broglio, Scott Berry, Alan E. Jones	27
14	Self-Perceptions of Proximal Stability as Measured by the Functional Movement Screen 2012 ·The Journal of Strength and Conditioning Research ·Thomas Palmer, Dana Howell, Carl G. Mattacola, Kert Viele	6
15	Statistics and bioinformatics in nutritional sciences: analysis of complex data in the era of systems biology 2010 ·The Journal of Nutritional Biochemistry ·Wenjiang J. Fu, Arnold J. Stromberg, Kert Viele, Raymond J. Carroll, Guoyao Wu	88
16	Influence of PCPA and MDMA (ecstasy) on physiology, development and behavior in Drosophila melanogaster 2007 ·European Journal of Neuroscience ·Sameera Dasari, Kert Viele, (unknown), Robin L. Cooper	35
17	Automated classification of evoked quantal events 2006 ·Journal of Neuroscience Methods ·M. Lancaster, Kert Viele, Andrew F.M. Johnstone, Robin L. Cooper	7
18	Self-modeling structure of evoked postsynaptic potentials 2006 ·Synapse ·Kert Viele, M. Lancaster, Robin L. Cooper	6
19	Estimating the number of release sites and probability of firing within the nerve terminal by statistical analysis of synaptic charge 2002 ·Synapse ·Kert Viele, Arnold J. Stromberg, Robin L. Cooper	14
20	LOGLINEAR MODELS AND GOODNESS-OF-FIT STATISTICS FOR TRAIN WAYBILL DATA 2001 ·(unknown), Kert Viele	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact